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Objective. Inhibition of inﬂammation and free radical formation in the cochlea may be involved in antioxidant treatment in
a c u t ea c o u s t i ct r a u m a .Procedure. Chinchilla were exposed to 105dB sound pressure level octave band noise for 6 hours. One
group of chinchilla was treated with antioxidants after noise exposure. Auditory brainstem responses, outer hair cell counts, and
immunohistochemical analyses of biomarkers in the cochlea were conducted. Results. The antioxidant treatment signiﬁcantly
reduced hearing threshold shifts, outer hair cell loss, numbers of CD45+ cells, as well as 4-hydroxy-2-nonenal and nitrotyrosine
formation in the cochlea. Conclusion. Antioxidant treatment may provide protection to sensory cells by inhibiting formation of
reactive oxygen and nitrogen products and migration of mononuclear phagocytes in the cochlea. The present study provides
further evidence of eﬀectiveness of antioxidant treatment in reducing permanent hearing loss.
1.Introduction
Metabolic oxidative stress plays a signiﬁcant role in acute
acoustic trauma (AAT) and provokes the production of
reactive oxygen species (ROS) and reactive nitrogen species
(RNS) in the inner ear [1–4]. In the cochlea, free radicals
and their products emerge or increase immediately after
high level noise exposure as well as a second peak that
occurs 7–12 days [2–8]. The direct relationship between the
formation of free radicals and AAT is not fully understood.
Free radicals may directly cause cochlear dysfunction and
DNA damage [5, 9, 10] and induce cell death in the inner ear
[11–14]. More importantly, a self-perpetuating reaction of
free radicals and ROS on lipid molecules may be responsible
for continuing cell damage after noise exposure [15]. ROS
and RNS may also cause mitochondrial membrane injury,
cytochrome C release, and ischemia/reperfusion damage and
trigger apoptotic cell death in the inner ear [15–19].
Based on these studies, a number of antioxidants were
studied either to enhance intrinsic cochlear stress defenses or
as exogenous antioxidants and have been successfully used to
prevent AAT through systemic or local application in several
animal models [20–27]. More importantly, postexposure
treatment in animal models [21, 24, 27, 28]p r o v i d e san e w
possible use of the antioxidants to treat AAT in the clinic in
the future.
Antioxidants target diﬀerent pathways in the inner ear.
For example, N-acetyl-L-cysteine (NAC) provides cysteine
for synthesis of reduced glutathione (GSH), which is an
important antioxidant compound in mitochondria [24, 28–
30]. Acetyl-L-carnitine (ALCAR) can restore mitochondrial
membraneintegrityandreduceROSproduction[16,25,29].2 International Journal of Otolaryngology
Protective mechanisms of 4-hydroxy phenyl N-tert-
butylnitrone (4-OHPBN), a major metabolite of phenyl
N-tert-butylnitrone (PBN), are still unclear although it has
been successfully used in the treatment of AAT [21, 31].
PBN is a spin trapping agent, and its phenyl ring reacts with
hydroxyl radicals [32]. Biological functions of PBN may
involve the reduction of oxidative stress and inﬂammation,
as well as attenuation of glutamate excitotoxicity [33, 34].
Although PBN was unable to reduce the auditory threshold
shifts induced by noise alone in rats [35, 36], the derivative,
4-OHPBN, alone or in combination with other antioxidants
can eﬀectively treat AAT in chinchilla, suggesting 4-OHPBN
may have diﬀerent biological functions compared to PBN
[21]. A three-drug combination (NAC + ALCAR + 4-
OHPBN) was signiﬁcantly better than any single antioxidant
treatment as reﬂected by hearing testing through auditory
brainstem responses (ABRs) and outer hair cell (OHC)
counts [21]. However, the underlying cellular and molecular
mechanisms of these antioxidants in treating AAT have not
yet been established.
At least 2 free radical products have been used as bio-
markers of oxidative stress to label ROS and RNS activity in
the inner ear and to evaluate eﬀects of antioxidant treatment
after noise exposure [6, 8, 27, 37]. Four-hydroxy-2-nonenal
(4-HNE) is an indicator of oxidative damage formed as an
abundant product of polyunsaturated fatty acid oxidation
and decomposition. 4-HNE reacts extensively with DNA and
proteins, depletes intracellular GSH, and alters many cell
signaling cascades [38]. Delayed 4-HNE formation has been
found in the organ of Corti of guinea pigs and was shown
to peak 7–10 days after a noise exposure of 120dB sound
pressure level (SPL) for 5 hours [8]. Nitrotyrosine (NT),
a marker of nitric oxide (NO) production, is formed by
nitration of a tyrosine residue in proteins [39]. Another free
radical biomarker, malondialdehyde, was found in cochlea
immediately after noise exposure as well as a second peak at
12 days [6, 7, 37]. We have examined these three free radical
biomarkers in the present study. Other biomarkers that were
also examined include cytoplasmic cytochrome C [40, 41],
inducible nitric oxide synthase (iNOS) [42, 43], and caspase
3[ 17, 40].
In recent years, the relationship between inﬂammation
and oxidative stress has been extensively studied in various
organs and systems, that is, pulmonary and cardiovascular
systems, CNS, liver, and muscle [44]. In the inner ear,
inﬂammatory cells have been found in diﬀerent structures
of the cochlea after noise exposure [45–47]. For example,
dendritic macrophages were noted in the organ of Corti
5 days after noise exposure [45]. A large increase in the
number of CD45+ cells was found in the spiral ligament
and spiral limbus 1–14 days after noise exposure [46, 47].
This inﬂammatory response may be involved in propagating
cellular damage in the cochlea after noise exposure [46].
Because oxidative stress and inﬂammation are traditionally
associated with AAT, we used an anti-CD45 antibody as an
inﬂammatory marker to examine the eﬀects of antioxidant
treatment on inﬂammation in the cochlea.
In the present study, the cochleae were examined using
semiquantitative immunohistochemical analyses 10 days
after noise exposure, a second time point that free radicals
reached a maximum [8], to evaluate the eﬀectiveness of
antioxidant treatment in AAT using inﬂammatory, oxidative
stress, and cell death biomarkers.
2.MaterialsandMethods
2.1. Animals. T h ee x p e r i m e n t a lp r o c e d u r e sw e r ea p p r o v e d
by the Institutional Animal Care and Use Committees of
the Oﬃce of Naval Research and the Oklahoma Medical
Research Foundation (OMRF). Eighteen female adult chin-
chilla laniger weighing 500–850g (3 to 5 years old) were
purchased from Moulton Chinchilla Ranch (Rochester, MN)
and housed in the OMRF animal facility with free access to
a standard chinchilla diet (Mazuri Chinchilla Diet, 5MO1,
PM1 Nutrition International Inc., Brentwood, MO) and tap
water throughout the experimental periods. The ambient
noise level in the animal facility was 54.7dB (A)/20.0uPa.
The chinchilla were randomized into 3 groups (n = 6
in each group): animals in the noise exposure plus carrier
solution (dimethyl sulfoxide, polyethylene glycol 400, and
saline) and noise plus treatment (noise/treatment) groups
were exposed to a 105dB SPL octave-band noise for 6 hours
(detailed below). Animals in the normal control group were
not exposed to noise.
2.2. Noise Exposure. For noise exposure, two animals at a
time were placed in two small wire restraint cages on a
wooden plate. They were exposed to a 105dB SPL octave-
band noise centered at 4kHz for 6h in a sound isolation
booth (Industrial Acoustics Company, New York, NY). The
noise generation was detailed in our previous report [21].
Brieﬂy, the noise was generated, ﬁltered by a Tucker Davis
Technologies (TDT, Alachua, FL) device, ampliﬁed (QSC
audio PLX 3402 power ampliﬁer, Costa Mesa, CA), and
transduced with an acoustic speaker (JBL 2350, Northridge,
CA). The dropoﬀ of noise energy outside the octave-band
noise being produced was 20–25dB/octave. The speaker
was suspended from the ceiling of the sound booth and
positioned directly above the wire cages. A condenser micro-
phone (B&K 2804, Norcross, GA) coupled to a preampliﬁer
and the PULSE software system (B&K Sound & Vibration
Measurement) was placed between the two wire cages at the
level of the animals’ heads to continually monitor the noise
level during noise exposure.
2.3.InjectionofAntioxidants. Animalsinthenoise/treatment
group received an initial injection 4 hours after the noise
exposure and then twice a day for the following 2 days.
Animals in this group received 20mg/kg of 4-OHPBN
dissolved in dimethyl sulfoxide, polyethylene glycol 400,
and saline, 50mg/kg of NAC (Hospira Inc., Lake Forest,
IL), and 20mg/kg of ALCAR (Sigma-Aldrich Inc. St. Louis,
MO). These agents were intraperitoneally administered. In
the noise exposure and the normal control groups, equal
volumes of carrier solution were injected at the same
time points as in the noise/treatment group. The three-
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combination showed the best hearing protection as reported
in our previous study [21].
2.4. Measurement of Auditory Brainstem Responses. ABR
thresholds for both ears of each animal were measured
before initial noise exposure (baseline threshold), imme-
diately after, and then 10 days after noise exposure. ABR
threshold shift was obtained as the diﬀerence between the
baseline threshold and the ﬁnal ABR threshold measured 10
days after noise exposure. The ABR recordings procedure
was detailed in our previous report [21]. Brieﬂy, animals
were lightly anesthetized with ketamine (20mg/kg) and
xylazine (1mg/kg). The ABR thresholds were determined
by decreasing the sound intensities of the tone pips (5ms
duration and 1ms Blackman rise/fall ramp at 0.5, 1, 2, 4,
6, and 8kHz) ﬁrst at 10dB steps until near the threshold
and then 5dB ascending steps. Threshold was deﬁned as the
midpoint between the lowest level of a clear response and
thenextlevelofnonresponse.Theinvestigatorsobtainingthe
ABR thresholds were blinded as to the identity of the animal
groups.
2.5. Tissue Collection and HC Counting. After the last ABR
measurement, the chinchilla were euthanized with an over-
dose of ketamine and xylazine and then intracardially
perfusedwith0.1Mphosphatebuﬀeredsaline(PBS,pH7.2),
followed by 4% paraformaldehyde in PBS. Cochleae were
removed and postﬁxed in the same ﬁxative overnight and
then washed in PBS and stored in the buﬀer at 4◦C. The
right cochlea from each animal was used for whole mount
andTRITC-phalloidinstainingforHCcounting.Percentages
of HCs were obtained by dividing the OHC count from the
experimental animals by the HC count from normal control
animalsforeachcochlearsection[48].Finally,thepercentage
of missing HCs was plotted as a function of percent distance
from the cochlear apex by entering inputs into a worksheet
to construct a cytocochleogram [21, 48]. An equation of
cochlear frequency-place map (F = 125e0.051d,w h e r eF is the
frequency in Hz and d is percent distance from the apex) was
used to evaluate HC losses at speciﬁc frequencies of 2, 4, 6,
and 8kHz [21, 49, 50]. The left cochlea from each animal
was processed for immunohistochemical analysis (detailed
below).
2.6.ImmunohistochemicalAnalysis. Cochleaewerewashedin
dH2O three times and immersed in 10% EDTA for 2 weeks
with 3-4 solution changes. After decalciﬁcation, the cochleae
were cryoprotected in 30% sucrose in PBS at 4◦C overnight,
embedded in Tissue-Tek (Sakura Finetek USA Inc. Torrance,
CA) and serially sectioned in a perimodiolar plane with a
Thermo Cryotome (Thermo Fisher Scientiﬁc, Inc. Waltham,
MA) at 18–20μm. Serial sections were mounted onto gelatin
precoated slides.
For ﬂuorescence immunohistochemical staining, the
sections were washed 3 times with PBS, blocked in 1%
bovine serum albumin (fraction V) and 1% normal goat
serum in PBS for 1 hour, and permeabilized in 0.2% triton
X-100 in PBS (PBS/T) for 30 minutes. The sections were
then incubated with a primary antibody (1:200 mouse anti-
nitrotyrosine IgG, Upstate, Lake Placid, NY; 1:100 rabbit
anti-4-hydroxy-2-nonenal Michael adducts IgG, chemically
reduced, EMD Chemicals, Inc. Gibbstown, NJ; 1:500 rabbit
anti-malondialdehyde polyclonal IgG, Chemicon Interna-
tional, Inc. Temecula, CA) for 2 hours. After washing with
PBS/T, Alexa Fluor 594 donkey antimouse or antirabbit IgG
(1:1000, Invitrogen, Carlsbad, CA) was applied onto the
slides for 1 hour. After rinsing with PBS, 4 , 6-diamidino-2-
phenylindole (DAPI, 1:20,000) was used for nuclear stain-
ing. A coverslip was applied with ProLong Gold Antifade
Reagent (Invitrogen, Carlsbad, CA). To eliminate possible
artiﬁcial eﬀects on ﬂuoresce intensity that may be caused by
diﬀerent staining conditions, each run of immunostaining
included the same number of slides from each group. Images
were collected with ﬂuorescence microscopy (Olympus
BX51, Melville, NY) or confocal microscopy (Leica SP2 Con-
focal Microscope, Heidenberg, Germany). Other primary
antibodies used in the ﬂuorescence immunohistochemical
staining include rabbit anticaspase 3 IgG (1:50, Millipore,
Temecula, CA), mouse anti-iNOS IgG (1:100, Abcam Inc,
Cambridge, MA), and rabbit anticytochrome C (1:50, Cell
Signaling Technology, Danvers, MA).
To study mononuclear phagocyte migration in the
cochleae, mouse anti-CD45 IgG1 (1:25, BD Pharmin-
gen, San Jose, CA) was incubated with cochlear sections
overnight. After PBS/T washing, biotinylated antimouse
IgG (1:200, Vector Laboratories, Inc. Burlingame, CA) was
applied onto the slides for 1 hour, and Vectastain ABC and
DAB kits (Vector Laboratories, Inc. Burlingame, CA) were
then used for the immunolabeling visualization. Immuno-
positive cells had a brown reaction product. Images were
collectedbylightmicroscopy(OlympusBX51,Melville,NY).
A negative control was obtained by omitting the primary
antibody in both ﬂuorescence and ABC immunohistochem-
ical analyses.
2.7. Quantitation of Immunostaining and Statistical Analysis.
A modiﬁed semiquantitative procedure [51]w a se m p l o y e d
to quantify CD45+ cells in the cochleae. Images were taken
by light microscopy (40x objective) from cross-sections
of the stria vascularis in every other section, and the
distance between two images was about 400μmt oe n s u r e
nonduplicate counting. Five to six images were collected
from each cochlear turn. CD45+ immunostaining density
was obtained by dividing the number of positive cells in each
cross-section of the stria vascularis by the cross-sectional
area of the stria vascularis (CD45+ density = number of
CD45+ cells/size of stria vascularis (per mm2)). The sizes of
the cross-sections of the stria vascularis were measured by
drawing a line along the border of the stria vascularis with
ImageJ software (National Institutes of Health). Only big
(>5-6μm) dark brown dots were counted to avoid counting
melanin in the stria vascularis.
Measurement of 4-HNE relative ﬂuorescence intensity in
the organ of Corti was conducted with LAS AF Lite software
(Leica Microsystems CMS GmbH, Heidenberg, Germany).
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midmodiolar sections of each cochlea by ﬂuorescence
microscopy using the same camera settings. The images were
taken only from midmodiolar sections so that a similar
shape and size of the organ of Corti could be measured
in all animals. The distance between two images was about
200–400μm to ensure non-duplicate measurement. Relative
ﬂuorescence intensity was measured with the software by
drawing a line along the border of the organ of Corti, from
which the mean pixel intensity of the labeling was derived.
A modiﬁed semiquantitative procedure [52]w a s
employed to count an NT immunostaining index in the
spiral ligament in three turns. Images were taken from
the spiral ligament by ﬂuorescence microscopy (40x). The
images were taken from every other section, and distance
between two sections was about 400μmt oe n s u r en o n -
duplicate counting. Five to six images were collected from
each turn. The total number of cells (number of nuclei
stained by DAPI) and NT positive cells in the image were
counted using the ImageJ software. An immunostaining
index was obtained by dividing the number of NT positive
cells by total number of cells within the image.
The cell counting and the intensity measurement were
conducted by a technician who was blinded as to the identity
of the animal groups. ABR and cell counting data are
reported as mean ± SEM. One-way ANOVA (SPSS 14.0
for windows) was used to statistically analyze the ABR
threshold shift and the missing OHC data between noise
exposure and noise/treatment groups and to determine if
there were statistically signiﬁcant diﬀerences among three
groups in CD45+ immunostaining density, 4-HNE relative
ﬂuorescenceintensity,andNTimmunostainingindex.When
a signiﬁcant diﬀerence was found in ANOVA, a post hoc
test (Tukey HSD) or a paired sample student t-test was used
for mean comparisons between groups. A P value of less
than 0.05 was considered to be signiﬁcant in the statistical
analyses.
3. Results
3.1. Antioxidant Treatment Attenuated Hearing Threshold
Shifts. The ABR thresholds were equivalent among three
groups prior to noise exposure (P>0.05 for all frequencies,
data not shown). Compared to baseline ABR thresholds
measured before the noise exposure, there are signiﬁcant
hearing threshold shifts in both the noise exposure and the
noise/treatment groups at all frequencies, but with larger
thresholdshiftsfoundinthenoiseexposuregroup,especially
at the higher frequencies (2–8kHz). As shown in Figure 1,
the mean ABR threshold shifts in the noise exposure group
ranged from ∼25dB at low frequencies (0.5–1kHz) to
∼51dBathighfrequencies(2–8kHz).Inthenoise/treatment
group, mean threshold shifts ranged from ∼10dB at the low
frequencies to ∼25dB at the high frequencies. Compared
to the noise exposure group, signiﬁcant reductions in
threshold shifts were found in the noise/treatment group
at all frequencies (0.5–8kHz, P<0.05,<0.01 or <0.001)
with greater reductions at the high frequencies (2–8kHz,
P< 0.001, Figure 1). The hearing threshold shift average at
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Figure 1: Average ABR threshold shifts at each frequency (0.5–
8kHz) 10 days after noise exposure. Hearing threshold shifts were
found in both the noise exposure and the noise/treatment groups at
all frequencies with greater shifts in the high frequencies (2–8kHz).
Compared to the noise exposure group, signiﬁcant reductions in
threshold shifts were found in the noise/treatment group at all
frequencies. There are signiﬁcant diﬀerences in the threshold shifts
between the noise exposure and the noise/treatment groups at all
frequencies, especially at high frequencies (∗∗∗, ∗∗,a n d∗ indicate
P<0.001,<0.01, and <0.05, resp. Error bars represent standard
error of the means. Number of ears = 12 in each group).
higher frequencies was ∼24dB in the noise/treatment group
and ∼51dB in the noise exposure group (P<0.001). The
ABR thresholds were equivalent between two measurements
(baseline and thresholds measured before subjects were
euthanized) in the normal non-noise exposed control group
(P>0.05 for all frequencies, data not shown). These results
indicate that antioxidant treatment used in the present study
can signiﬁcantly attenuate hearing loss induced by AAT.
3.2. Antioxidant Treatment Reduced OHC Loss. As shown in
the cytocochleogram in Figure 2, the majority of missing
OHCs in the noise exposure group were located at the
region of 55–95% of the distance from cochlear apex,
representing frequencies ranging from 2 to12kHz. This
may mirror the HC damage/death pattern in the cochlea
exposed to a narrow band noise, in which HC death had
spread apically and basally from the initial regions of injury
[53]. Reduced OHC loss was found in the noise/treatment
group compared to the noise exposure group, especially
at the 55–100% distance from cochlear apex. There was a
signiﬁcant diﬀerence between these two groups in the mean
percentagesofOHClossinthecochleae(P<0.001).Average
percentages of missing OHCs at regions corresponding to
cochlear frequencies ranging from 2 to 8kHz were ∼60% in
the noise exposure group and ∼25% in the noise/treatment
group. There was a signiﬁcant diﬀerence between these two
groups in the average OHC loss at the high frequency region
(P<0.001).Theseresultsindicatethatantioxidanttreatment
signiﬁcantly reduced OHC loss from AAT.International Journal of Otolaryngology 5
0
20
40
60
80
100
3 9 14 20 26 31 37 43 48 54 60 66 71 77 83 88 94100
M
i
s
s
i
n
g
O
H
C
s
(
%
)
Distance from apex (%)
Noise exposure (n = 6)
Noise+treatment (n = 6)
Figure 2: A cytocochleogram representing mean percentage of
missing OHCs at the measured percent distance from the cochlear
apexinthenoiseexposureandthenoise/treatmentgroups.Reduced
OHC loss was found in the noise/treatment group compared to
the noise exposure group, especially at the 55–100% distance from
cochlear apex. There is a signiﬁcant diﬀerence between these two
groups in average OHC loss in the cochleae (P<0.001, error bars
represent standard error of the means. Number of cochleae = 6i n
each group).
3.3. Antioxidant Treatment Reduced CD45+ Cell Migration
into the Lateral Wall. As shown in Figure 3,af e wC D 4 5 +
cells were found in the stria vascularis of the normal control
group (arrows in Figure 3(a)), but not in the spiral ligament
or in the organ of Corti (data not shown). However, a
signiﬁcantly increased number of CD45+ cells were detected
in the stria vascularis of the noise exposure group (arrows
in Figure 3(b)). CD45+ cells in the stria vascularis were
primarily found in the basal and intermediate cell layers
with a few in the marginal cell layer. Compared to the
noise exposure group, a signiﬁcantly decreased number
of CD45+ cells were found in the stria vascularis of the
noise/treatment group (arrows in Figure 3(c)). A few CD45+
cells were also found in the spiral ligament of the noise
exposure and the noise/treatment groups (arrowheads in
Figures 3(b) and 3(c)). Figure 3(d) displays the results of the
CD45+ immunostaining density measurement in the stria
vascularis at each turn of the cochleae of all three groups.
Two sets of ANOVA and post hoc tests (Tukey HSD) were
conducted in the statistical analyses. Firstly, we analyzed the
CD45+ immunostaining densities among the three groups
at each turn (basal, middle, or apical). The results indicated
that there were statistically signiﬁcant diﬀerences among the
three groups at each turn (all P<0.001). The post hoc
test (Tukey HSD) demonstrated that there were signiﬁcant
diﬀerences in pairwise comparisons among the three groups
(normal control versus noise exposure; normal control ver-
sus noise/treatment; noise exposure versus noise/treatment)
at each turn (P<0.05 or <0.001). Then, we analyzed the
CD45+ immunostaining densities among the three turns in
each group. The levels of CD45+ cells at three turns are
equivalent in the normal control group (all P>0.05), as
well as in the noise exposure group (all P>0.05), but a
signiﬁcantly reduced number of CD45+ c e l l sw e r ef o u n di n
the middle turns compared to those in the basal turn in
the noise/treatment group (P<0.01). These results suggest
thatantioxidanttreatmentsigniﬁcantlyreducedmigrationof
CD45+ cellsintothestriavascularisofthreeturnsofcochleae
and that the treatment was more eﬃcient in the middle turn
than in the basal turn. CD45+ cells were occasionally seen in
the organ of Corti in the noise exposure and noise/treatment
groups (data not shown). No CD45+cells were found in the
spiral ganglia of all three groups (data not shown).
3.4. Antioxidant Treatment Reduced 4-HNE Formation in
the Organ of Corti. No positive 4-HNE staining was found
in the cochleae of the normal control group (Figure 4(a)).
However, in the noise-exposed cochleae, positive staining
wasfoundin theorganof Corti in allthreeturns.Inthebasal
turns, positive 4-HNE staining was shown in inner hair cells
(IHCs) as well as Deiters and Hensen cells while most OHCs
were missing in this area, which is consistent with the OHC
counting data. In the middle turn, strong positive staining
was found in IHCs (arrow in Figure 4(b)) and in most
supporting cells (SCs, inner and outer pillar cells, Deiters
cells, and cells of Hensen and Boetthcher, arrowheads and
starburst in Figure 4(b)). The OHC region had relative weak
4-HNE immunostaining (bracket in Figure 4(b)). 4-HNE
immunostaining in the organ of Corti of the noise/treatment
group was more similar to the staining of the normal control
group (Figure 4(c)). There were statistically signiﬁcant dif-
ferences among the three groups in the relative ﬂuorescence
intensity in each turn (ANOVA, all P<0.001). In each
turn, signiﬁcant diﬀerences were found between the normal
controlandthenoiseexposuregroups,aswellasbetweenthe
noise exposure and the noise/treatment groups (P<0.001),
but not between the normal control and the noise/treatment
groups (Tukey HSD, P>0.05, Figure 4(d)). There was no
signiﬁcant diﬀerence among basal, middle, and apical turns
within each group (all P>0.05). These results indicate that
antioxidant treatment signiﬁcantly reduced the formation of
4-HNE to control levels in the organ of Corti at all three
turns. No positive 4-HNE immunostaining was found in the
lateral wall of cochlea or in the spiral ganglia of all three
groups (data not shown).
3.5. Antioxidant Treatment Inhibited NT Formation in the
Spiral Ligament. As shown in Figure 5(a), no signiﬁcant NT
immunostaining was found in the spiral ligament of the
normal control group. However, strong positive staining was
found in the spiral ligament of the noise exposure group.
The staining was located in the cytoplasm of ﬁbrocytes
(arrows in Figure 5(b)). A signiﬁcantly reduced number
of NT positive cells were found in the spiral ligament of
the noise/treatment group (Figure 5(c)). Figure 5(d) displays
results of the immunostaining index measurement in the
spiral ligament in the cochlear three turns. There were
statistically signiﬁcant diﬀerences among the three groups in
each turn (ANOVA, all P<0.001). The post hoc test (Tukey
HSD) demonstrated that there were signiﬁcant diﬀerences
between the normal control and noise exposure groups in all6 International Journal of Otolaryngology
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Figure 3:CD45+ immunostainingandimmunostainingdensityinthestriavascularis.ExamplesofCD45+ immunostainingimagesobtained
from the stria vascularis in the middle turn of cochleae from the normal control (a), noise exposure (b), and noise/treatment (c) groups by
light microscopy. Few CD45+ cells were found in the stria vascularis of the normal group (arrows in (a)). There was a large increase in
the number of CD45+ cells in the stria vascularis of the noise exposure group (arrows in (b)). The antioxidant treatment signiﬁcantly
decreased the number of CD45+ cells in the stria vascularis (arrows in (c)). CD45+ cells were also found in the spiral ligament of the noise
and the noise/treatment groups (arrowheads in b and c), but not in the normal control group. The results of the immunostaining density
measurement are shown in (d) (number of cochleae = 6 in each group). There were signiﬁcant diﬀerences among the three groups and
in pairwise comparisons in the three groups in each turn. The numbers (1, 2, 3) in (d) indicate the normal control, noise exposure, and
noise/treatment groups, respectively. Scale bar = 20μm in (c) for (a)–(c) (error bars represent standard error of the means. ∗, ∗∗, ∗∗∗ in-
dicates P<0.05, 0.01, 0.001, resp. Number of cochleae = 6 in each group).
threeturns(P<0.001),aswellasbetweenthenoiseexposure
and the noise/treatment groups in basal and middle turns
(P<0.01 or <0.001), indicating that antioxidant treatment
signiﬁcantly inhibited NT formation in the spiral ligament
in the basal and middle turns. There was trend toward
reduced NT formation in the apical turn; however, there
was no statistically signiﬁcant diﬀerence between the noise
exposure and the noise/treatment groups in the apical turns.
Additionally, there was no signiﬁcant diﬀerence between the
normalcontrolandthenoise/treatmentgroupsinthemiddle
turn, indicating that the treatment was more eﬃcient in the
middle turn than in the basal turn. The level of NT positive
cells was equivalent among diﬀerent turns in each group (all
P>0.05). No signiﬁcant NT immunostaining was found in
theorganofCortiorinthespiralganglionofallthreegroups
(data not shown).
3.6. Some Biomarkers Did Not Show Signiﬁcant Positive Stain-
ing in the Cochleae 10 Days after Noise Exposure. Biomarkers
for malondialdehyde, cytochrome C, iNOS, and caspase 3International Journal of Otolaryngology 7
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Figure 4: 4-HNE immunostaining and relative ﬂuorescence intensity in the organ of Corti. Examples of 4-HNE immunostaining images
obtained from the organ of Corti in the middle turn of cochleae from the normal control (a), noise exposure (b) and noise/treatment
(c) groups by confocal microscopy using the same microscopic and image collecting settings. No signiﬁcant 4-HNE staining was found in
the organ of Corti of the normal control group (a). Strong positive staining was seen in IHC (arrow in (b)), inner and outer pillar cells
(open arrowheads in (b)), Deiters cells (arrowheads), and cells of Hensen (starburst) and Boettcher of the noise exposure group. The OHC
region also had positive, but relatively weak 4-HNE immunostaining (bracket in B). Signiﬁcantly lower HNE staining was found in the
organ of Corti in the noise/treatment group (c). The results of the relative ﬂuorescence intensity in the organ of Corti measured by LAS
AF Lite software are shown in (d). High ﬂuorescence intensity was found only in the organ of Corti of the noise exposure group. There
were signiﬁcant diﬀerences among three groups and between the normal control and the noise exposure groups, as well as between the
noise exposure and the noise/treatment groups (∗∗∗indicates P<0.001). However, there was no signiﬁcant diﬀerence between the normal
control and the noise/treatment groups (P>0.05). There was no signiﬁcant diﬀerence among three turns within each group (P>0.05). The
numbers (1, 2, 3) in (d) indicate the normal control, noise exposure and noise/treatment groups, respectively. Brackets indicate the OHC
region in (a)–(c). Scale bar = 20μm in (c) for (a)–(c) (Error bars represent standard error of the means. Number of cochleae = 6i ne a c h
group).
showed no signiﬁcant positive staining in the cochleae of
all three groups. The lack of signiﬁcant positive expression
of these biomarkers in the cochleae might be associated
with the time point examined and noise intensity used in
the present study. Most of these biomarkers are present in
the cochlea early after noise exposure. For example, a high
concentration of malondialdehyde was found in the cochlea
immediately after noise exposure with a second peak at 12
days [6,7,37].Apoptotic celldeathhasbeen foundprimarily
in the OHCs from a few minutes to 4 days after noise
exposure [17, 40]. Upregulation of iNOS was found in the
cochleafromimmediatelytoabout1dayafternoiseexposure
[42, 43].
4. Discussion
This study demonstrates that noise exposure of 105dB SPL
for 6 hours induced an ABR threshold shift of about 40–
45dB in chinchilla. The same noise exposure resulted in only
about a 20dB threshold shift in the animals that received8 International Journal of Otolaryngology
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Figure 5: NT immunostaining and immunostaining index in the spiral ligament. Examples of NT immunostaining images obtained from
the spiral ligament in the middle turn of cochleae in the normal control (a), the noise exposure (B), and the noise/treatment (c) groups by
confocal microscopy. No signiﬁcant NT immunostaining was found in the spiral ligament of the normal control group (A). A large number
of NT positive cells were found in the spiral ligament of the noise exposure group (arrows in (b)) while a signiﬁcantly decreased number
of NT positive cells were found in the noise/treatment group (arrows in (c)). The results of the immunostaining index are shown in (d).
A high NT immunostaining index was found in the spiral ligament in all three turns of the noise exposure group. There were signiﬁcant
diﬀerences between the normal control and the noise exposure groups in the cochlear three turns, and between the noise exposure and the
noise/treatmentgroupsinthebasalandmiddleturns.Therewasnosigniﬁcantdiﬀerencebetweenthenoiseexposureandthenoise/treatment
groups in the apical turn. The numbers (1, 2, 3) in (d) indicate the normal control, noise exposure, and noise/treatment groups, respectively
(∗∗∗ and ∗∗ indicate P<0.001 and <0.01, resp.). Scale bar = 20μm in (c) for (a)–(c) (error bars represent standard error of the means.
Number of cochleae = 6 in each group).
the three-antioxidant combination treatment. Consistent
with the functional protection, the treatment signiﬁcantly
rescued 40–50% of OHCs from AAT. These results are
consistent with previous reports using the same noise level
and duration [21, 28, 29, 31, 54] although the results in
the present study were obtained 10 days, instead of 21
days, after noise exposure. The ABR threshold shifts in
the present study were higher than those recorded at 21
days after noise by 12–15dB, which may represent residual
temporary threshold shift. Our semiquantitative data have
demonstrated that formation of oxidative stress biomarkers
and migration of mononuclear phagocytes in the cochleae
were signiﬁcantly reduced by the antioxidant treatment.
There are two signiﬁcant ﬁndings in the present study. First,
the present study demonstrates that antioxidant treatment
caninhibitanaspectofinﬂammationinthecochlea,andthis
inhibition was associated with functional and histological
recovery with the antioxidant treatment. Second, the present
study has provided further evidence that this three-drug
combination treatment protects the cochlea from oxidative
injury in AAT.
4.1. The Role of Inﬂammatory Response in the Cochlea
after Noise Exposure and Antioxidant Treatment. CD45,International Journal of Otolaryngology 9
acommonleukocyteantigen,ispresentonallbone-marrow-
derived white blood cells. Normally, only a few CD45+ cells
are found in the cochlea, but the number of CD45+ cells
was signiﬁcantly increased in the noise-exposed cochleae
[46, 47, 55]. Consistent with these reports, increases in
CD45+ cells were found in the stria vascularis and the
spiral ligament of the noise exposed cochleae in the present
study. Furthermore, the current study has demonstrated
that the antioxidant treatment signiﬁcantly inhibited the
migration of CD45+ cells into the cochlea by 20–58%,
suggesting that inhibition of inﬂammation appears to be
a new mechanism of antioxidant treatment in AAT. The
present study has also suggested as others have noted that
inhibition of inﬂammation may be a strategy to treat AAT
[56].
Althoughthepreviousandpresentstudieshavesuggested
that therapeutic beneﬁts can be obtained from inhibition
of inﬂammation in AAT [56], the role of inﬂammatory
cells in the noise-exposed cochleae is still disputed. It has
been proposed that inﬂammatory cells migrate into the
cochlea to clear cellular debris resulting from noise-exposure
and contribute to wound healing [46, 47]. However, this
hypothesis is not supported by the fact that no inﬂammatory
cells have been found in the organ of Corti, which is most
severely injured by noise exposure. Loss of OHCs without
any evidence of inﬂammatory response in the cochlea has
also been documented [57]. The number of macrophages
in the cochleae did not correlate with the damage level
in the organ of Corti because an almost equal number of
macrophages were found in cochleae exposed for 2 hours
either to 112 or 120dB SPL octave band noise (8–16KHz)
[46]. One possibility is that the inﬂammatory cells may
activate a cochlear immune response and cause more cellular
damage in the cochlea [47, 58]. A recent study demonstrated
that the excessive inﬁltration of hematogenous macrophages
caused more HC loss in the cochlea after kanamycin
ototoxicity [59]. However, suppression of the inﬂammatory
response in the cochlea could not prevent delayed HC
loss although functional protection and increased ganglion
neuron survival have been observed in a mouse AAT model
[56]. Therefore, the inﬂammatory response may not directly
contribute to the HC loss in the noise-damaged cochlea.
Migrationofinﬂammatorycellsintothecochleamayinitially
bearesponsetothecellulardamageintheorganofCorti,but
these inﬂammatory cells cause cell death in the lateral wall
[46]. This argument is supported by acute swelling and loss
of intermediate cells in the stria vascularis and loss of type II
and type IV ﬁbrocytes in the spiral ligament after high levels
(112 or 116dB SPL for 2 hours) of noise exposure [60, 61].
Macrophages are also a source of NO production in early
stages of wound healing [62] and may partially contribute
to the formation of RNS in the cochlea. If this is the case,
antioxidant treatment could reduce secondary injury to the
cochlea induced by the inﬂammatory response.
One question is why the majority of the CD45+ cells
are located in the lateral wall of the cochlea, but only
very few in the organ of Corti? The major sources of the
inﬂammatorycytokines(i.e.,IL-1α,IL-6,tumornecrosisfac-
tor α, macrophage inﬂammatory protein-2, and monocyte
chemoattractant protein-1) are the ﬁbrocytes and external
sulcuscellslocatedwithinthelateralwall[63,64].Expression
of these inﬂammatory mediators is increased in the lateral
wallinearlystagesafternoiseexposure[47,55,65],andthese
mediators would attract the inﬂammatory cells migrating
into the lateral wall initially and then into other tissues of
the cochlea.
4.2. The Role of RNS and ROS in the Cochlea after Noise
Exposure and Antioxidant Treatment. In the present study,
strong 4-HNE staining was found in IHCs and SCs 10 days
after noise exposure; however, only weak positive staining
was found in the OHC region. The positively stained SCs
included inner and outerpillar cells,Deiters cells, and cellsof
Hensen and Boettcher (Figure 4(b)). This expression pattern
was also found in the organ of Corti 21 days after noise
exposure although the ﬂuorescence intensity at 21 days was
much weaker than that at 10 days (unpublished data). In
a previous report, strong 4-HNE staining was detected in
all cells of the organ of Corti in guinea pigs 10 days after
120dB SPL, 5 hours of noise exposure [8]. The 4-HNE
staining pattern in the present study is more like the staining
pattern at day 7 after the noise exposure in that report (see
Figure 5(d) in [8]). These results suggest that noise intensity
might be an important factor aﬀecting distribution of 4-
HNE product in cells of the organ of Corti. Furthermore,
4-HNE was found in IHCs and SCs immediately after noise
exposure [8] and still can be seen 21 days later, indicating
that 4-HNE might form early and stay longer in IHCs
and SCs than that in OHCs. Clearance of 4-HNE in the
survivingOHCsbeginsaround14daysaftertheintensenoise
exposure [8] and probably before 10 days after a relative low
dose of noise exposure used in the present study. Another
possibility is that dying OHCs may be losing 4-HNE staining
during the course of degeneration. It has been found that
delayed degeneration of OHC develops for 4 weeks after
noise exposure [66, 67].
However, how 4-HNE causes OHC loss is still unclear.
Exposing organotypic cultures of the organ of Corti of 3
day old mouse pups to 4-HNE (75–150uM), we found
many more SCs undergoing necrotic and apoptotic cell
death than OHCs, suggesting that 4-HNE may primarily
cause SC death leading to OHC death (unpublished data).
Majority of IHCs survived in the cochleae of chinchilla
in both the noise exposure and noise/treatment groups
(IHC loss was 1.90% and 1.06%, resp.) although IHC had
strong 4-HNE staining, suggesting IHCs are less sensitive
to 4-HNE damage. Signiﬁcantly lower expression of 4-HNE
was found in the organ of Corti of the noise/treatment
group, suggesting that the antioxidant treatment inhibits the
formation of 4-HNE in the organ of Corti. Consistent with
our in vivo results, GSH treatment can protect inner ear
HCs and hippocampal neurons from 4-HNE injury in vitro
[68, 69]. Taken together, results in all of these reports and
the present study indicate a relationship between 4-HNE
formation and cochlear cell death in AAT [27] and that
inhibition of 4-HNE formation in the cochlea may be one
of the reasons why antioxidant treatment is eﬀective in AAT.10 International Journal of Otolaryngology
Strong NT staining was found in the spiral ligament of
thenoiseexposuregroup,whichwaslocatedinthecytoplasm
of ﬁbrocytes, the predominant cell type in this area. The spi-
ral ligament is one of the nonsensory structures susceptible
to AAT. Type II and IV ﬁbrocytes in this area are signiﬁcantly
reduced after noise exposure [60, 70]. The strong expression
of NT in the ﬁbrocytes of the spiral ligament may be
involvedinthelossoftypeIVﬁbrocytesafternoiseexposure.
Other free radicals (O2−, 8-isoprostane, NO, NT) were also
detected in the spiral ligament immediately or few hours
after noise exposure [1, 3, 5]. The function of ﬁbrocytes
in the spiral ligament was thought to be a purely passive
role of structural support. However, increasing evidence
suggests that they play more important and dynamic roles in
the cochlea, such as potassium ion recycling, inﬂammatory
reactions, and glutamate metabolism [71–73]. Loss of type
IV ﬁbrocytes may be a primary cause of age-related hearing
loss and ultimate sensory cell degeneration in the C57BL/6J
mouse [74]. After drug treatment, a signiﬁcantly decreased
expressionofNTwasfoundinthespiralligament,suggesting
that the drug treatment inhibits NT formation in the
spiral ligament. The current results imply that antioxidant
treatment may provide additional protection to the cochlea
through inhibiting RNS formation in the spiral ligament.
However, we did not ﬁnd any signiﬁcant NT staining in
the organ of Corti or in the spiral ganglion 10 days after
noiseexposure,suggestingthatformationofRNSmaybenot
directly involved in OHC loss or neuron loss when examined
at this time point.
The results of 4-HNE and NT immunostaining showed
no gradients for the various turns of the cochlea 10 days
after noise exposure, yet the OHC loss and ABR threshold
shifts were not uniform throughout the cochlea. These
results suggest that noise exposure can promote free radical
formation throughout the cochlea. However, the apical HCs
are more resistant to free radicals than HCs in the basal and
middle turns [75].
4.3. Possible Mechanisms of the Antioxidants in Treating AAT.
In this three-drug combination, NAC provides cysteine
for synthesis of GSH, works as a free radical scavenger,
and inhibits cell death pathways [24, 28, 29]. ALCAR
reduces ROS production and preserves mitochondria by
serving as a precursor of acetyl-CoA, a mitochondrial
energy substrate, and restoring a key mitochondrial lipid,
cardiolipin, in oxidatively injured cells [16, 25, 29]. The
nitrone, 4-OHPBN, is designed to scavenge free radicals
as its phenyl ring reacts with hydroxyl radicals and may
also decrease inﬂammation by inhibiting inﬂammatory
mediators [32, 33, 76]. The precursor of 4-OHPBN, PBN,
has been shown to have strong anti-inﬂammatory eﬀects.
PBN can decrease inducible cyclooxygenase (COX2) and
iNOS mRNA levels, inhibit COX2 catalytic activity and
lipopolysaccharide-mediated increase of nuclear factor Kap-
paB (NF-KappaB) DNA binding activity [34]. COX2, iNOS,
and NF-KappaB are important inﬂammatory mediators.
Thus, 4-OHPBN is likely to be the major component in
the three-drug combination to play an anti-inﬂammatory
role. Therefore, the action of each of these three-drugs
contributes separately to the attenuation of free radical
formationandinﬂammatoryresponsesinthecochleatotreat
AAT.Thepotentialmechanismsoftherapeuticeﬀectsofeach
antioxidantwillbeassessedinourlaboratoryinanupcoming
set of experiments.
5. Conclusion
The present study conﬁrms the functional and HC protec-
tionofthisthree-antioxidantcombinationtreatmentinAAT.
The results of our semiquantitative immunohistochemical
analyses have demonstrated that the antioxidant treatment
reduced not only formation of biomarkers for oxidative
stressbutalsomigrationofmononuclearphagocytesintothe
cochlea. The ﬁnding in the present study that antioxidants
can inhibit inﬂammatory responses in the cochlea suggests
a new role for antioxidants in treating AAT in the future.
These results have also conﬁrmed that multiple damage
mechanisms are involved in AAT and that simultaneous
attenuation of these mechanisms at diﬀerent sites in the
cochlea using a combination of antioxidants to treat AAT
may be eﬀective [27].
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